IDEXX Laboratories, Inc. (BMV:IDXX)

Market Cap	877.92B +21.8%
Revenue (ttm)	77.48B +10.4%
Net Income	19.07B +19.3%
EPS	235.48 +22.6%
Shares Out	n/a
PE Ratio	46.03
Forward PE	44.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	48
Open	11,170
Previous Close	11,170
Day's Range	11,170 - 11,170
52-Week Range	7,650 - 14,130
Beta	n/a
RSI	44.01
Earnings Date	Feb 2, 2026

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: IDXX

Financial Performance

In 2025, IDEXX Laboratories's revenue was $4.30 billion, an increase of 10.42% compared to the previous year's $3.90 billion. Earnings were $1.06 billion, an increase of 19.33%.

Financial numbers in USD